Correction: Evidence of brain target engagement in Parkinson's disease and multiple sclerosis by the investigational nanomedicine, CNM- Au8, in the REPAIR phase 2 clinical trials

Affiliations

• ¹ Department of Neurology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA.
• ² Parkinson's Disease and Movement Disorders Center, Boca Raton, FL, 33486, USA.
• ³ 3Clene Nanomedicine, Inc., 6550 S Millrock Dr., Suite G50, Salt Lake City, UT, 84121, USA.
• ⁴ Instat Clinical Research, A Veristat Company, 1 Wilson St., Chatham, NJ, 07928, USA.
• ⁵ 3Clene Nanomedicine, Inc., 6550 S Millrock Dr., Suite G50, Salt Lake City, UT, 84121, USA. karen@clene.com.